KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $10.08 $17.49 Friday, 26th Apr 2024 CRIS stock ended at $14.47. This is 0.344% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.09% from a day low at $14.25 to a day high of $14.69.
90 days $8.24 $17.49
52 weeks $0.380 $17.49

Historical Curis prices

Date Open High Low Close Volume
Mar 23, 2023 $0.560 $0.560 $0.513 $0.520 318 968
Mar 22, 2023 $0.536 $0.560 $0.536 $0.550 275 976
Mar 21, 2023 $0.540 $0.540 $0.500 $0.506 542 959
Mar 20, 2023 $0.550 $0.550 $0.510 $0.511 290 977
Mar 17, 2023 $0.560 $0.561 $0.520 $0.540 348 487
Mar 16, 2023 $0.520 $0.588 $0.500 $0.561 428 000
Mar 15, 2023 $0.580 $0.620 $0.520 $0.528 485 170
Mar 14, 2023 $0.585 $0.620 $0.560 $0.560 596 752
Mar 13, 2023 $0.640 $0.660 $0.556 $0.576 1 135 943
Mar 10, 2023 $0.670 $0.681 $0.620 $0.629 527 099
Mar 09, 2023 $0.669 $0.707 $0.657 $0.679 488 418
Mar 08, 2023 $0.680 $0.694 $0.650 $0.663 249 179
Mar 07, 2023 $0.690 $0.713 $0.680 $0.694 242 160
Mar 06, 2023 $0.687 $0.710 $0.687 $0.710 275 449
Mar 03, 2023 $0.628 $0.750 $0.628 $0.690 908 399
Mar 02, 2023 $0.634 $0.640 $0.610 $0.637 464 451
Mar 01, 2023 $0.620 $0.650 $0.615 $0.630 434 354
Feb 28, 2023 $0.628 $0.637 $0.611 $0.622 247 866
Feb 27, 2023 $0.618 $0.660 $0.603 $0.629 298 436
Feb 24, 2023 $0.630 $0.641 $0.610 $0.616 192 044
Feb 23, 2023 $0.660 $0.665 $0.630 $0.630 202 944
Feb 22, 2023 $0.646 $0.670 $0.617 $0.646 310 256
Feb 21, 2023 $0.690 $0.690 $0.621 $0.634 347 449
Feb 17, 2023 $0.668 $0.694 $0.650 $0.685 293 346
Feb 16, 2023 $0.686 $0.700 $0.660 $0.661 502 080
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT